Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post –Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response—A Single-Center Study

Patients after liver transplantation (LT) with hepatitis C virus (HCV) infection often suffer from renal or hepatic impairment. Treating patients after LT with direct-acting antivirals (DAA) might result in decreasing renal function due to interaction of DAA and immunosuppressive therapy. In this single-center study we analyzed clinical parameters of 18 HCV-infected patients treated with DAA therapy after LT.
Source: Transplantation Proceedings - Category: Transplant Surgery Authors: Tags: Milestones in Transplantation Source Type: research